Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) (BSCC-H306)

Recombinant Anti-CD89 x Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD89 antibody variable domain is fused to CH1 and the other scFv from an anti-HIV-1 gp41 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget macrophages to tumor cells. It is designed for the research of HIV-1 infection, AIDS therapy.

Datasheet INQUIRY

Specifications

Targets

CD89 & HIV-1 gp41

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

HIV-1 infection, AIDS

Targets

Target 1

CD89

Gene ID

2204

UniProt ID

P24071

Alternative Names

FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor

Target 2

HIV-1 gp41

Gene ID

155971

UniProt ID

Q0H5Z9

Alternative Names

ENV; gp160; Envelope glycoprotein 120; envelope glycoprotein; Envelope surface glycoprotein gp160, precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain; human immunodeficiency virus type 1; human immunodeficiency virus type 1 gp120; human immunodeficiency virus type 1 glycoprotein 120; gp41; GP41; glycoprotein 41

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) (BSCC-H306). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD89 x Human Anti-HIV-1 gp41 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-H306)

Specifications

Targets

Customer Reviews and Q&As